Sulodexide Terminated Phase 4 Trials for Diabetic Nephropathies Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00130312Effect of Sulodexide in Overt Diabetic Nephropathy